These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 15277221

  • 21. Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas.
    Adachi Y, Aoki C, Yoshio-Hoshino N, Takayama K, Curiel DT, Nishimoto N.
    Int J Cancer; 2006 Sep 15; 119(6):1303-11. PubMed ID: 16642474
    [Abstract] [Full Text] [Related]

  • 22. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
    Blanchard F, Kinzie E, Wang Y, Duplomb L, Godard A, Held WA, Asch BB, Baumann H.
    Oncogene; 2002 Sep 12; 21(41):6264-77. PubMed ID: 12214267
    [Abstract] [Full Text] [Related]

  • 23. IL-6/IL-6 receptor system and its role in physiological and pathological conditions.
    Mihara M, Hashizume M, Yoshida H, Suzuki M, Shiina M.
    Clin Sci (Lond); 2012 Feb 12; 122(4):143-59. PubMed ID: 22029668
    [Abstract] [Full Text] [Related]

  • 24. No inhibition of IL-27 signaling by soluble gp130.
    Scheller J, Schuster B, Hölscher C, Yoshimoto T, Rose-John S.
    Biochem Biophys Res Commun; 2005 Jan 28; 326(4):724-8. PubMed ID: 15607729
    [Abstract] [Full Text] [Related]

  • 25. Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions.
    Dahmen H, Horsten U, Küster A, Jacques Y, Minvielle S, Kerr IM, Ciliberto G, Paonessa G, Heinrich PC, Müller-Newen G.
    Biochem J; 1998 May 01; 331 ( Pt 3)(Pt 3):695-702. PubMed ID: 9560294
    [Abstract] [Full Text] [Related]

  • 26. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.
    Jostock T, Müllberg J, Ozbek S, Atreya R, Blinn G, Voltz N, Fischer M, Neurath MF, Rose-John S.
    Eur J Biochem; 2001 Jan 01; 268(1):160-7. PubMed ID: 11121117
    [Abstract] [Full Text] [Related]

  • 27. JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells.
    De Vos J, Jourdan M, Tarte K, Jasmin C, Klein B.
    Br J Haematol; 2000 Jun 01; 109(4):823-8. PubMed ID: 10929036
    [Abstract] [Full Text] [Related]

  • 28. IL-6 receptor independent stimulation of human gp130 by viral IL-6.
    Müllberg J, Geib T, Jostock T, Hoischen SH, Vollmer P, Voltz N, Heinz D, Galle PR, Klouche M, Rose-John S.
    J Immunol; 2000 May 01; 164(9):4672-7. PubMed ID: 10779772
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Suppression of IL-6 production and proliferation by blocking STAT3 activation in malignant soft tissue tumor cells.
    Shouda T, Hiraoka K, Komiya S, Hamada T, Zenmyo M, Iwasaki H, Isayama T, Fukushima N, Nagata K, Yoshimura A.
    Cancer Lett; 2006 Jan 18; 231(2):176-84. PubMed ID: 16399222
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Human T-cell leukemia virus type-I Tax induces expression of interleukin-6 receptor (IL-6R): Shedding of soluble IL-6R and activation of STAT3 signaling.
    Horiuchi S, Yamamoto N, Dewan MZ, Takahashi Y, Yamashita A, Yoshida T, Nowell MA, Richards PJ, Jones SA, Yamamoto N.
    Int J Cancer; 2006 Aug 15; 119(4):823-30. PubMed ID: 16557588
    [Abstract] [Full Text] [Related]

  • 34. The regenerative activity of interleukin-6.
    Galun E, Rose-John S.
    Methods Mol Biol; 2013 Aug 15; 982():59-77. PubMed ID: 23456862
    [Abstract] [Full Text] [Related]

  • 35. STAT3 is constitutively activated in Hodgkin cell lines.
    Kube D, Holtick U, Vockerodt M, Ahmadi T, Haier B, Behrmann I, Heinrich PC, Diehl V, Tesch H.
    Blood; 2001 Aug 01; 98(3):762-70. PubMed ID: 11468177
    [Abstract] [Full Text] [Related]

  • 36. Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression.
    Oguro T, Ishibashi K, Sugino T, Hashimoto K, Tomita S, Takahashi N, Yanagida T, Haga N, Aikawa K, Suzutani T, Yamaguchi O, Kojima Y.
    Eur J Cancer; 2013 May 01; 49(7):1715-24. PubMed ID: 23274199
    [Abstract] [Full Text] [Related]

  • 37. Expression levels of gp130 in bone marrow stromal cells determine the magnitude of osteoclastogenic signals generated by IL-6-type cytokines.
    O'Brien CA, Lin SC, Bellido T, Manolagas SC.
    J Cell Biochem; 2000 Sep 14; 79(4):532-41. PubMed ID: 10996844
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.